Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Doravirine Concentrations and Antiviral Activity in Genital Fluids in HIV-1 Infected Individuals

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT04097925
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:35.522817+00:00
Published At
2022-05-25T00:00:00+00:00
Record Updated At
2022-07-06
Results Posted At
2022-05-25
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["HIV-1-infection"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2022-07-06"
protocolSection.identificationModule.nctId
"NCT04097925"
protocolSection.identificationModule.officialTitle
"Doravirine Concentrations and Antiviral Activity in Genital Fluids in HIV-1 Infected Individuals"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2022-05-25"

Study condition terms

  • HIV-1-infection (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.